For the Inventor, By the Inventor

Enter assignee name

Calgary, Canada

Synsorb Biotech, Inc.

USPTO Granted Patents = 34

CIPO Patents = 4

Forward Citations = 123

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Glen D Armstrong (20 out of 38 patents)

Louis D Heerze (13 out of 21 patents)

Ole Hindsgaul (11 out of 29 patents)

4. Bradley G Thompson (3 out of 76 patents)

5. David J Rafter (3 out of 3 patents)

6. Robert M Ratcliffe (3 out of 11 patents)

7. Keiko Sujino (2 out of 16 patents)

8. David C Schriemer (2 out of 14 patents)

9. Monica Marija Palcic (2 out of 5 patents)

10. Francois Auclair (2 out of 2 patents)

11. Hermy Lior (2 out of 2 patents)

12. George A Wells (2 out of 2 patents)

13. Andrew M MacKenzie (2 out of 2 patents)

14. Paul R Goodyer (2 out of 2 patents)

15. Terrance P Klassen (2 out of 2 patents)

34 patents: Sort by Forward Citations

1. 6528274 - Method for the production of sialylated oligosaccharides (2003-03-04),

2. 6465435 - Treatment of C. difficile toxin B associated conditions (2002-10-15),

3. 6358930 - Treatment of C. difficile toxin B associated conditions (2002-03-19),

4. 6224891 - Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions (2001-05-01),

5. 6194178 - Method for the production of sialylated oligosaccharides (2001-02-27),

6. 6191418 - Device for delivery of multiple liquid sample streams to a mass spectrometer (2001-02-20),

7. 6177553 - Solid phase synthesis of thio-oligosaccharides (2001-01-23),

8. 6174867 - 1-galactose derivatives having a carbon- or nitrogen-containing aglycon linkage (2001-01-16),

9. 6121242 - Treatment of bacterial dysentery (2000-09-19),

10. 6107282 - Treatment of C. difficile toxin B associated conditions (2000-08-22),

11. 6087339 - Saccharide derivatives (2000-07-11),

12. 6069137 - Treatment of traveller's diarrhea (2000-05-30),

13. 6063769 - 1-thiogalactose derivatives (2000-05-16),

14. 6054047 - Apparatus for screening compound libraries (2000-04-25),

15. 6013635 - Treatment of C. difficile toxin B associated conditions (2000-01-11),

Synsorb Biotech, Inc. is a biotechnology company dedicated to pioneering innovative solutions for the treatment and prevention of infectious diseases. With a focus on developing therapeutic products, vaccines, and diagnostics, Synsorb Biotech aims to address unmet medical needs and improve global healthcare. Headquartered in [Headquarter Location], we collaborate with leading research institutions and industry partners to deliver high-quality and safe biotech solutions. Our commitment to advancing scientific knowledge and benefiting patients drives our mission to create a healthier future.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

34 Patents

#21 in Calgary

#375 in Canada

#19,027 in the World

Calgary, Canada

Synsorb Biotech, Inc.

Forward Citations = 123

30 inventors:

Glen D Armstrong (20 out of 38 patents)

Louis D Heerze (13 out of 21 patents)

Ole Hindsgaul (11 out of 29 patents)

4. Bradley G Thompson (3 out of 76 patents)

5. David J Rafter (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…